arrow
Return

Novel Probucol Analogue, 4,4′-Diselanediylbis (2,6-Di-tert-Butylphenol), Prevents Oxidative Glutamate Neurotoxicity In Vitro and Confers Neuroprotection in a Rodent Model of Ischemic Stroke

delete2023-07-27
delete6
PRE
AI
M
Maurício Tavares Jacques
V
Viviane de Souza
F
Flavio A. R. Barbosa
R
Rômulo Faria Santos Canto
S
Samantha Cristiane Lopes
R
Rui Daniel Prediger
A
Antônio L. Braga
M
Michael Aschner
M
Marcelo Farina *
DOI:10.1021/acschemneuro.3c00138delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Oxidative glutamate toxicity is regardedas one of the injuriousmechanisms associated with ischemic stroke, which represents a majorhealth problem and requires improved pharmacological treatments. Wedesigned and synthesized two new probucol analogues [2,6-di-tert-butyl-4-selenocyanatophenol ( C1 ) and 4,4 & PRIME;-diselanediylbis (2,6-di-tert-butylphenol) ( C2 )] and investigatedtheir effects against glutamate-induced neuronal oxidative toxicity in vitro in cultured HT22 cells, compared with their parentalcompound (probucol). In addition, C2 , which exhibited the lowest toxicity, was investigated in an in vivo rodent model of ischemic stroke. Glutamate causedconcentration- and time-dependent cytotoxicity in HT22 neuronal cells,which was preceded by increased levels of oxidants and depletion ofthe antioxidant glutathione. The analogues ( C1 and C2 ), but not probucol,significantly decreased the levels of oxidants (including mitochondrialsuperoxide anion and lipid reactive oxygen species (ROS)) and protectedagainst glutamate-induced cytotoxicity. In the in vivo model of ischemic stroke, which was based on central injectionsof the vasoconstrictor agent endothelin-1 (800 pmol/site), C2 (20 or 50 mg/kg/day, intraperitoneally,for 4 consecutive days after stroke) displayed significant beneficialeffects against ischemic injury in vivo, improvingrats' motor-related behavioral skills and decreasing stroke-relatedstriatal gliosis. This is the first study to design, synthesize, andpresent a probucol analogue ( C2 ) with in vivo beneficial effects against ischemic stroke. Thisnovel compound, which was able to mitigate glutamate-induced oxidativetoxicity in vitro, represents a promising neuroprotectivedrug.
Keywords:
probucol analogues
ischemic stroke
oxidativeglutamate toxicity
endothelin-1
neuroprotection

Journal

ACS Chemical Neuroscience cover
ACS Chemical Neuroscience
IF:
3.9
Papers:
4.5K
Citations:
1.3W

Organization

A
Albert Einstein College of Medicine
Scholars:
1.2W
Papers: 8.6K
Citations: 2.4W
M
Montefiore Medical Center
Scholars:
1.9W
Papers: 1.3W
Citations: 5.8K
U
universidade federal de santa catarina (ufsc)
Scholars:
1.5W
Papers: 1.0W
Citations: 9
researcher View more organizations